The 2024 Virginia Conference on Youth Tobacco Use

Call for Posters

A poster session will be held in conjunction with lunch of the first day of the conference, April 15th, from 12:00 to 1:30. This is a perfect opportunity to present your research on the causes and prevention of youth tobacco use, including preliminary findings of research in progress or conceptual models that may be tested through future research. The poster session is open to all university faculty and students, public agency staff, and VFHY grantees.  

The poster session will also include a Student Poster Award competition that is open to all undergraduate and graduate students. To be eligible, you must be a student and indicate in your submission that you wish to participate Student Poster Award. During the poster session, posters will be judged by a panel of experts and the winner will be announced during the conference welcome on April 16th, 2024. There will be two awards of $350 each.

Appropriate topics for poster presentations are research covering the broad spectrum of methods and approaches related to increasing our understanding and improving the prevention of youth tobacco use. Thus, poster presentations may include basic research including the biological and behavioral mechanisms associated with tobacco use and nicotine dependence; measurement research, including the development of new instruments to assess the processes and outcomes of preventive interventions; clinical research, including the translation of basic research into new interventions and testing the efficacy of interventions with new populations; epidemiological research, including genetic epidemiology and studies to determine the incidence and prevalence of youth tobacco use and addiction in Virginia and among specific subpopulations; and services research, including the financing and organization of services, effectiveness studies, and the studies of effective methods for disseminating science-based interventions. 

Submissions will be reviewed for appropriateness (i.e., they must address a topic related to the etiology and/or prevention of youth tobacco use as described above).  All appropriate submissions will be accepted if received by the submission due date of March 1st at 5pm. 

For consideration, the primary affiliation of all persons submitting an abstract must be a college/university, public agency or VFHY grantee.

To submit a proposal for a poster presentation, send a brief (no more than 250 words) abstract of the poster presentation along with a listing of authors and their institutional affiliation to Dr. Chelsea Williams at The subject line of the e-mail should be the name of the first author followed by the words “VYTP Poster Presentation.” You will be notified of the acceptance of your poster presentation no later than March 15th, 2023. At that time you will be given guidelines for the preparation of the poster.

 In preparing the abstract, please follow the guidelines below:

  • If you wish to enter the student poster competition, please indicate that by adding Student Poster Contestant at the top of the abstract.
  • The body of the abstract should be one paragraph, single spaced, with 1-inch margins. Abstracts should be a maximum of 250 words.
  • The abstract, including title, author listing, institutional affiliation and the body of the abstract must fit on one page.
    Prepare the abstract in MS Word, Times New Roman, 12.
  • The first line should be the title of the poster.
  • The authors should be listed following the title. Include each author’s first and last name, and middle initial if desired. Please do not include degrees.
  • After the authors, list the institutional affiliation and location for each author.
  • No graphics or tables should be included in the abstract.
  • Deadline: March 1.

This research is supported by the National Institute on Drug Abuse of the National Institutes of Health and the Center for Tobacco Products of the U.S. Food and Drug Administration under Award Number U54DA036105. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration